Literature DB >> 16436794

Decreased mortality by normalizing blood glucose after acute ischemic stroke.

Nina T Gentile1, Michael W Seftchick, Tien Huynh, Linda K Kruus, John Gaughan.   

Abstract

OBJECTIVES: Hyperglycemia after cerebral ischemia exacerbates brain injury and worsens the outcome of stroke patients. The authors sought to examine the effect of glycemic control on mortality after acute stroke.
METHODS: This was a retrospective study of patients discharged with a diagnosis of ischemic stroke during a 40-month period from a large urban U.S. health system. Patients were compared by initial blood glucose (BG) levels and by glycemic control during the first 48 hours of hospitalization.
RESULTS: Of 960 patients with thromboembolic stroke, 373 (38.9%) were hyperglycemic (BG > or = 130 mg/dL) on hospital admission. Admission hyperglycemia was associated with a higher mortality rate than was euglycemia (odds ratio [OR] = 3.15; 95% confidence interval [CI] = 1.45 to 6.85; p = 0.004). Persistent hyperglycemia (PerHyp) during 48 hours of hospitalization was associated with even higher mortality rate (unadjusted logistic regression, OR = 6.54; 95% CI = 2.41 to 17.87; p < 0.001). Glycemic control (normalization of BG to < 130 mg/dL) was associated with a 4.6-fold decrease in mortality risk as compared with the case of patients with PerHyp (p < 0.001). Multiple logistic regression showed glycemic control to be a strong independent determinant of survival (OR = 5.95; 95% CI = 1.24 to 28.6; p = 0.026) after acute stroke even after adjustment for age, gender, concomitant hypertension and diabetes, and stroke severity.
CONCLUSIONS: Admission hyperglycemia is associated with a worse outcome after stroke than is euglycemia. Normalization of blood glucose during the first 48 hours of hospitalization appears to confer a potent survival benefit in patients with thromboembolic stroke.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16436794     DOI: 10.1197/j.aem.2005.08.009

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  37 in total

1.  Morinda citrifolia fruit juice prevents ischemic neuronal damage through suppression of the development of post-ischemic glucose intolerance.

Authors:  Shinichi Harada; Wakako Fujita-Hamabe; Kohei Kamiya; Yoshiyuki Mizushina; Toshiko Satake; Shogo Tokuyama
Journal:  J Nat Med       Date:  2010-06-24       Impact factor: 2.343

Review 2.  Care of the stroke patient: routine management to lifesaving treatment options.

Authors:  George A Lopez; Arash Afshinnik; Owen Samuels
Journal:  Neurotherapeutics       Date:  2011-07       Impact factor: 7.620

Review 3.  Considering hyperglycemia and thrombolysis in the Stroke Hyperglycemia Insulin Network Effort (SHINE) trial.

Authors:  Andrew M Southerland; Karen C Johnston
Journal:  Ann N Y Acad Sci       Date:  2012-09       Impact factor: 5.691

4.  Efficiency and safety of a standardized protocol for intravenous insulin therapy in ICU patients with neurovascular or head injury.

Authors:  Salmaan Kanji; Erika Jones; Rob Goddard; Hilary E Meggison; David Neilipovitz
Journal:  Neurocrit Care       Date:  2009-09-24       Impact factor: 3.210

5.  Effect of chronic endothelin receptor antagonism on cerebrovascular function in type 2 diabetes.

Authors:  Alex K Harris; Mostafa M Elgebaly; Weiguo Li; Kamakshi Sachidanandam; Adviye Ergul
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-02-20       Impact factor: 3.619

6.  Diabetes mellitus, acute hyperglycemia, and ischemic stroke.

Authors:  Askiel Bruno; David Liebeskind; Qing Hao; Radoslav Raychev
Journal:  Curr Treat Options Neurol       Date:  2010-11       Impact factor: 3.598

Review 7.  Glycemic variability and acute ischemic stroke: the missing link?

Authors:  Emmanuel I González-Moreno; Carlos R Cámara-Lemarroy; José G González-González; Fernando Góngora-Rivera
Journal:  Transl Stroke Res       Date:  2014-08-03       Impact factor: 6.829

8.  Effect of chronic and selective endothelin receptor antagonism on microvascular function in type 2 diabetes.

Authors:  Kamakshi Sachidanandam; Mostafa M Elgebaly; Alex K Harris; Jim R Hutchinson; Erin M Mezzetti; Vera Portik-Dobos; Adviye Ergul
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-04-18       Impact factor: 4.733

9.  Glucose levels and insulin secretion in surgery-induced hyperglycemia in normoglycemic obese patients.

Authors:  Marina Michalaki; Venetsana Kyriazopoulou; Panagiotis Mylonas; Maria-Ioanna Argentou; Yves Debaveye; Fotis Kalfarentzos; Apostolos G Vagenakis
Journal:  Obes Surg       Date:  2008-05-10       Impact factor: 4.129

10.  Aggressive glucose control for acute ischemic stroke patients by insulin infusion.

Authors:  Nayoung Kim; Yunsook Jhang; Jong-Moo Park; Byung-Kun Kim; Ohyun Kwon; Jungju Lee; Ji-Sung Lee; Ja-Seong Koo
Journal:  J Clin Neurol       Date:  2009-12-31       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.